ReviewMedical sciences (Basel, Switzerland)2025

Efficacy of Tyrosine Kinase Inhibitors in ALK and EGFR-Mutated Non-Small Cell Lung Cancer with Brain Metastases.

Walid Shalata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.